|
132 |
Fermentation 101 – Bioprocess Development, Optimization & Scale-up
|
관리자 |
2025-09-30 |
664 |
|
131 |
Joint stakeholders consultation on the revision of Chapter 4 on Documentation, Annex 11 on Computerised Systems and on the new Annex 22 on Artificial Intelligence of the PIC/S and EU GMP Guides
|
관리자 |
2025-09-30 |
802 |
|
130 |
The New FDA Era Of Radical Transparency And Pervasive Oversight
|
관리자 |
2025-09-12 |
1,033 |
|
129 |
How AI Is Revolutionizing Quality Management Systems
|
관리자 |
2025-09-12 |
830 |
|
128 |
Change Management from an Authorities Perspective
|
관리자 |
2025-09-12 |
554 |
|
127 |
5 Best Practices For Improving AI Literacy In A GxP Environment
|
관리자 |
2025-08-04 |
974 |
|
126 |
ECA - FAQs regarding Cross Contamination
|
관리자 |
2025-08-04 |
724 |
|
125 |
Audit Trail Compliance And What To Look For In Mitigation Software
|
관리자 |
2025-08-04 |
815 |
|
124 |
Regulatory Trends in Pharma Manufacturing: Key Changes to Watch in 2025
|
관리자 |
2025-07-04 |
869 |
|
123 |
Why Pharmacovigilance Is More Critical Than Ever
|
관리자 |
2025-07-04 |
911 |
